Resource Logo
New York Times

Roche Cleared For H.I.V. Test




 

Roche Holding A.G., Europe's fifth-largest drug maker, said today that it had won United States Food and Drug Administration clearance to sell a new, more sensitive version of its Amplicor test, designed to measure the amount of H.I.V. in a patient's blood.

Roche said it could now offer patients and doctors the most sensitive device available to doctors to tell whether they are succeeding in wiping out a patient's H.I.V., the virus that causes AIDS. Amplicor is 10 times more sensitive than tests currently available, picking up H.I.V. concentrations as low as 50 copies of the virus per milliliter of blood, Roche said.

H.I.V. can elude even the most powerful combinations of drugs by slightly shifting its genetic material almost every time it reproduces. Existing drugs fail to contain the virus in about half of patients.

These kinds of tests will be of most immediate use to doctors managing drug-resistant patients -- the vast majority of H.I.V. patients on therapy. Analysts estimate 90,000 to 100,000 H.I.V. patients switch drugs every year in an effort to keep ahead of H.I.V.



 


Copyright © 1999 -New York Times, Publisher. All rights reserved to New York Times company. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

Information in this article was accurate in March 4, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.